Attovia Therapeutics, Inc. Common Stock (ATTO)

Attovia Therapeutics, Inc. Common Stock (ATTO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $784M; returns 1 day -4.6%, 1 week +0.7%.

Attovia Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel biotherapeutics for immune-mediated, inflammatory, and pruritic diseases. The company leverages its proprietary ATTOBODY platform, designed to create high-affinity, bi- and multi-specific biologics with optimized pharmacokinetics and tissue distribution.

Groups ATTO belongs to

• Recent IPOs
• Business Process Outsourcing
• Industrials
• CRM Platform
• B2B Services
• Latin America
• Outsourcing
• Brazil
• Artificial Intelligence

ATTO financial model: income statement, cash flow and balance sheet